カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のリキッドバイオプシー市場2022年～2026年

■ 英語タイトル：Global Fluid Biopsy Market 2022-2026

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR45000-22）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR45000-22
■ 発行日：2022年4月21日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他地域
■ 産業分野：医療
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のリキッドバイオプシー市場2022年～2026年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

テクナビオ社は、世界のリキッドバイオプシー市場規模が2022年から2026年まで年平均18.77％成長し、17.4億ドルに達すると予測しています。本調査レポートでは、リキッドバイオプシーの世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、技術別（CTC＆ctDNA、エクソソーム＆RNA）分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の内容を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のリキッドバイオプシー市場規模：技術別（CTC＆ctDNA、エクソソーム＆RNA）
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Liquid Biopsy Market 2022-2026

Technavio has been monitoring the liquid biopsy market and it is poised to grow by $ 1.74 bn during 2022-2026, accelerating at a CAGR of 18.77% during the forecast period. Our report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer, growing focus on personalized medicine for cancer care, and increasing focus on early detection of cancer.

The liquid biopsy market analysis includes the technology segment and geographic landscape.
Technavio’s liquid biopsy market is segmented as below:

By Technology
• CTC and ctDNA
• exosome and RNA

By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing funding/investment for fluid biopsy as one of the prime reasons driving the liquid biopsy market growth during the next few years. Also, strategic partnerships and M&A and emerging applications of fluid biopsy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on liquid biopsy market covers the following areas:
• Liquid biopsy market sizing
• Liquid biopsy market forecast
• Liquid biopsy market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include AccuraGen Holdings, Adaptive Biotechnologies Corp., ANGLE Plc, Bio Rad Laboratories Inc., Biocept Inc., CellMax Inc., Epigenomics AG, F. Hoffmann La Roche Ltd., GeneFirst Ltd., Guardant Health Inc., HansaBioMed Life Sciences Ltd., Illumina Inc., MDNA Lfe Sciences Inc., MDxHealth Group, NeoGenomics Laboratories Inc., QIAGEN NV, Rarecells Inc., SAGA Diagnostics AB, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/liquid-biopsy-market-industry-size-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Technology
o 5.1 Market segments
o Exhibit 24: Chart on Technology – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Technology – Market share 2021-2026 (%)
o 5.2 Comparison by Technology
o Exhibit 26: Chart on Comparison by Technology
o Exhibit 27: Data Table on Comparison by Technology
o 5.3 CTC and ctDNA – Market size and forecast 2021-2026
o Exhibit 28: Chart on CTC and ctDNA – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on CTC and ctDNA – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on CTC and ctDNA – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on CTC and ctDNA – Year-over-year growth 2021-2026 (%)
o 5.4 Exosome and RNA – Market size and forecast 2021-2026
o Exhibit 32: Chart on Exosome and RNA – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Exosome and RNA – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Exosome and RNA – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Exosome and RNA – Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Technology
o Exhibit 36: Market opportunity by Technology ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Canada – Market size and forecast 2021-2026
o Exhibit 62: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.9 Germany – Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.10 UK – Market size and forecast 2021-2026
o Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.11 France – Market size and forecast 2021-2026
o Exhibit 74: Chart on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on France – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on France – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Bio Rad Laboratories Inc.
o Exhibit 85: Bio Rad Laboratories Inc. – Overview
o Exhibit 86: Bio Rad Laboratories Inc. – Business segments
o Exhibit 87: Bio Rad Laboratories Inc. – Key news
o Exhibit 88: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 89: Bio Rad Laboratories Inc. – Segment focus
o 10.4 F. Hoffmann La Roche Ltd.
o Exhibit 90: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 91: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 92: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 93: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 94: F. Hoffmann La Roche Ltd. – Segment focus
o 10.5 GeneFirst Ltd.
o Exhibit 95: GeneFirst Ltd. – Overview
o Exhibit 96: GeneFirst Ltd. – Product / Service
o Exhibit 97: GeneFirst Ltd. – Key offerings
o 10.6 Guardant Health Inc.
o Exhibit 98: Guardant Health Inc. – Overview
o Exhibit 99: Guardant Health Inc. – Product / Service
o Exhibit 100: Guardant Health Inc. – Key news
o Exhibit 101: Guardant Health Inc. – Key offerings
o 10.7 HansaBioMed Life Sciences Ltd.
o Exhibit 102: HansaBioMed Life Sciences Ltd. – Overview
o Exhibit 103: HansaBioMed Life Sciences Ltd. – Product / Service
o Exhibit 104: HansaBioMed Life Sciences Ltd. – Key offerings
o 10.8 Illumina Inc.
o Exhibit 105: Illumina Inc. – Overview
o Exhibit 106: Illumina Inc. – Business segments
o Exhibit 107: Illumina Inc. – Key news
o Exhibit 108: Illumina Inc. – Key offerings
o Exhibit 109: Illumina Inc. – Segment focus
o 10.9 MDxHealth Group
o Exhibit 110: MDxHealth Group – Overview
o Exhibit 111: MDxHealth Group – Business segments
o Exhibit 112: MDxHealth Group – Key offerings
o Exhibit 113: MDxHealth Group – Segment focus
o 10.10 QIAGEN NV
o Exhibit 114: QIAGEN NV – Overview
o Exhibit 115: QIAGEN NV – Product / Service
o Exhibit 116: QIAGEN NV – Key news
o Exhibit 117: QIAGEN NV – Key offerings
o 10.11 Rarecells Inc.
o Exhibit 118: Rarecells Inc. – Overview
o Exhibit 119: Rarecells Inc. – Product / Service
o Exhibit 120: Rarecells Inc. – Key offerings
o 10.12 Siemens Healthcare GmbH
o Exhibit 121: Siemens Healthcare GmbH – Overview
o Exhibit 122: Siemens Healthcare GmbH – Business segments
o Exhibit 123: Siemens Healthcare GmbH – Key news
o Exhibit 124: Siemens Healthcare GmbH – Key offerings
o Exhibit 125: Siemens Healthcare GmbH – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Technology – Market share 2021-2026 (%)
Exhibits25: Data Table on Technology – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Technology
Exhibits27: Data Table on Comparison by Technology
Exhibits28: Chart on CTC and ctDNA – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on CTC and ctDNA – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on CTC and ctDNA – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on CTC and ctDNA – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Exosome and RNA – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Exosome and RNA – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Exosome and RNA – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Exosome and RNA – Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Technology ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France – Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Bio Rad Laboratories Inc. – Overview
Exhibits86: Bio Rad Laboratories Inc. – Business segments
Exhibits87: Bio Rad Laboratories Inc. – Key news
Exhibits88: Bio Rad Laboratories Inc. – Key offerings
Exhibits89: Bio Rad Laboratories Inc. – Segment focus
Exhibits90: F. Hoffmann La Roche Ltd. – Overview
Exhibits91: F. Hoffmann La Roche Ltd. – Business segments
Exhibits92: F. Hoffmann La Roche Ltd. – Key news
Exhibits93: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits94: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits95: GeneFirst Ltd. – Overview
Exhibits96: GeneFirst Ltd. – Product / Service
Exhibits97: GeneFirst Ltd. – Key offerings
Exhibits98: Guardant Health Inc. – Overview
Exhibits99: Guardant Health Inc. – Product / Service
Exhibits100: Guardant Health Inc. – Key news
Exhibits101: Guardant Health Inc. – Key offerings
Exhibits102: HansaBioMed Life Sciences Ltd. – Overview
Exhibits103: HansaBioMed Life Sciences Ltd. – Product / Service
Exhibits104: HansaBioMed Life Sciences Ltd. – Key offerings
Exhibits105: Illumina Inc. – Overview
Exhibits106: Illumina Inc. – Business segments
Exhibits107: Illumina Inc. – Key news
Exhibits108: Illumina Inc. – Key offerings
Exhibits109: Illumina Inc. – Segment focus
Exhibits110: MDxHealth Group – Overview
Exhibits111: MDxHealth Group – Business segments
Exhibits112: MDxHealth Group – Key offerings
Exhibits113: MDxHealth Group – Segment focus
Exhibits114: QIAGEN NV – Overview
Exhibits115: QIAGEN NV – Product / Service
Exhibits116: QIAGEN NV – Key news
Exhibits117: QIAGEN NV – Key offerings
Exhibits118: Rarecells Inc. – Overview
Exhibits119: Rarecells Inc. – Product / Service
Exhibits120: Rarecells Inc. – Key offerings
Exhibits121: Siemens Healthcare GmbH – Overview
Exhibits122: Siemens Healthcare GmbH – Business segments
Exhibits123: Siemens Healthcare GmbH – Key news
Exhibits124: Siemens Healthcare GmbH – Key offerings
Exhibits125: Siemens Healthcare GmbH – Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の天然痘治療市場2022年～2026年
  • 世界の皮膚科用医薬品市場2022年～2026年
  • 世界のシコクビエ市場2022年～2026年
  • 世界の電動航空機市場2022年～2026年
  • 世界のバイオ医薬品分析検査サービス市場2022年～2026年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR45000-22 )"世界のリキッドバイオプシー市場2022年～2026年" (英文：Global Fluid Biopsy Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。